Monkeypox Information Center
Elsevier's free resource for clinical information and research on the monkeypox virus
Monkeypox — a zoonotic viral disease endemic to western and central Africa — has become a public health emergency of international concern. It's spread via direct contact, respiratory droplets, and contaminated materials and surfaces. Monkeypox is caused by the monkeypox virus, which belongs to the Orthopoxvirus genus of the Poxviridae family; other members of Orthopoxvirus include variola virus (which causes smallpox), vaccinia virus (used in smallpox vaccines), cowpox virus, and various other animal poxviruses. Monkeypox classically presents with rash, fever, lymphadenopathy, and a clinical course similar to that of smallpox but milder; case fatality rates of 3% to 6% have been reported in African countries where the disease is endemic, and Brazil, Spain and India have reported the first monkeypox deaths outside of endemic countries.
This information, from ClinicalKey, is available in Elsevier's Monkeypox Healthcare Hub — one of various resources we are offering here for clinicians, researchers and public health officials. All content here is freely available and will be continually updated.
Clinical information
To help healthcare professionals respond to the outbreak, Elsevier has created the Monkeypox Healthcare Hub. Here you will find evidence-based clinical resources, including clinical overviews, patient education and drug monographs.
Research
Elsevier journals and books monkeypox collection
We are identifying monkeypox-related articles and book chapters and making them freely available on ScienceDirect for the duration of the crisis. Several hundred articles and book chapters were made available by August 10, 2022, and new content is being added continuously.
We are also in the process of making this collection available as a machine-readable corpus to enable advanced discovery methods and identification of patterns and relationships in data (text and data mining).
Visit ScienceDirect to search for monkeypox content
The Lancet monkeypox collection
The Lancet Group is publishing the latest monkeypox-related content in epidemiology, treatments, and much more. Here you can explore monkeypox content published across Lancet journals and content types. All of our monkeypox content is free to access.
In addition, here are some key research articles from Elsevier journals
- Clinical features and management of human monkeypox: a retrospective observational study in the UK, The Lancet Infectious Diseases (August 2022)
- Global human monkeypox outbreak: atypical presentation demanding urgent public health action, The Lancet Microbe (August 2022)
- Monkeypox in 2022: A new threat in developing, Annals of Medicine and Surgery (June 2022)
- The new face of monkeypox virus: an emerging global emergency, New Microbes and New Infections (April–May 2022)
- Smallpox, Monkeypox, and Other Poxvirus Infections, ScienceDirect Topics: Pharmacology, Toxicology and Pharmaceutical Science
Early-stage research on SSRN’s Monkeypox Hub
Rapidly evolving healthcare emergencies necessitate the quick dissemination of research. SSRN — Elsevier’s platform for the rapid worldwide dissemination of early-stage research — is committed to making authors' monkeypox-related preprints available immediately. Their Monkeypox Hub provides a curated view into new early-stage research to help researchers, public health authorities, clinicians and the public understand, contain, navigate, and manage the current outbreak. By presenting insights from many disciplines, they hope to inform the ongoing conversation about the monkeypox virus.
Research on SSRN is free to download and upload. It is important to note that these preprints have not benefited from the pivotal role of the peer-review process, which validates and improves the quality of final published journal articles.
Search for monkeypox preprints on SSRN
Monkeypox datasets on Mendeley Data
We have selected datasets indexed by the Data Monitor search engine on the 2022 monkeypox outbreak to make it easier to find potentially relevant datasets for this topic.
Vaccination
Here are some monographs related to monkeypox vaccines and treatment, via Elsevier Health:
- Cidofovir (June 2, 2022)
- Smallpox and Monkeypox Vaccine, Live, Nonreplicating (July 8, 2022)
- Smallpox Vaccine, Vaccinia Vaccine (Aug 1, 2022)
- Tecovirimat (July 28, 2022)
- Vaccinia Immune Globulin, VIG (June 7, 2022)
Public health
Here, you will find guidance and commentary from experts along with official guidance from major health organizations. For research on public health, see the Research section.
What do HIV and COVID-19 have to do with monkeypox?
As monkeypox spreads, what lessons can we apply from the last two pandemics? Elsevier author Prof Rodney Rohde of Texas State University — a microbiologist and infectious disease expert — weighs in. Read his editorial
Lancet podcast
What’s happening with monkeypox in Africa? Why wasn’t monkeypox tackled when we had the chance? What will the PHEIC declaration change? For this episode of The Lancet Voice, Prof Yap Boum, Epicentre Representative for Africa, the research arm of Medecins sans Frontières, joins Gavin Cleaver and guest host Dr Miriam Lewis Sabin, North American Executive Editor of The Lancet.
Official websites
- World Health Organization (WHO)
- Centers for Disease Control (CDC)
- Public Health Agency of Canada (PHAC)
- European Centre for Disease Prevention and Control
- Nigeria Centre for Disease Control
- Johns Hopkins Medicine
- Center for Infectious Disease Research and Policy (CIDRAP)